Glenmark to spin off originator drugs business
The US-based subsidiary will bring together existing research and development and manufacturing businesses in the US, India and Switzerland.
Harbour BioMed raises $85M in Series B funding round
The company has been busy forming development and commercialization partnerships with other firms to develop antibodies in oncology and rheumatology.
Tips for Greater Healthcare Practice Success in 2025
Join us on February 26 at 3 pm ET, and we’ll dive into the key areas where practices are losing time and money and provide solutions to overcome them.